The QTERVAMET brand, founded in 2015 (Sweden), from 585 sister brands and 17478 competing brands. QTERVAMET is owned by ASTRAZENECA, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB0009895292. QTERVAMET belongs to the Drug Manufacturers business sector.